Inventor · disambiguated record
Ralph Minter
Also filed as: MINTER RALPH · MINTER RALPH R · MINTER RALPH RAYMOND
31 granted patents·20 pending applications·196 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
51 records- 0194US9938356B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2015·Granted Apr 10, 2018·26 cites·9 claims
- 0291US10287362B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2018·Granted May 14, 2019·10 cites·15 claims
- 0391US7901684B2Antibodies against human IL-22 and uses thereforWYETH LLC·Filed 2007·Granted Mar 8, 2011·14 cites·10 claims
- 0491US7452537B2P-cadherin antibodiesAGOURON PHARMA·Filed 2006·Granted Nov 18, 2008·40 cites·9 claims
- 0590US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0689US10844114B2Anti-Pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Nov 24, 2020·3 cites·21 claims
- 0789US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0888US7947273B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2007·Granted May 24, 2011·10 cites·18 claims
- 0987US10370436B2Anti-pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Aug 6, 2019·5 cites·5 claims
- 1087US2024124596A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1184US8263075B2Antibody molecule for human GM-CSF receptor alphaCOHEN EMMA SUZANNE·Filed 2007·Granted Sep 11, 2012·6 cites·10 claims
- 1284US7935343B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2004·Granted May 3, 2011·14 cites·45 claims
- 1383US9403901B2Anti-pseudomonas Psl binding molecules and uses thereofDIGIANDOMENICO ANTONIO·Filed 2012·Granted Aug 2, 2016·9 cites·14 claims
- 1483US8506960B2Antibody molecule for human GM-CSF receptor alphaCOHEN EMMA SUZANNE·Filed 2007·Granted Aug 13, 2013·5 cites·15 claims
- 1583US8507656B2Stabilized angiopoietin-2 antibodies and uses thereofBEDIAN VAHE·Filed 2009·Granted Aug 13, 2013·6 cites·15 claims
- 1682US9884902B2CTLA-4 variantsMEDIMMUNE LLC·Filed 2013·Granted Feb 6, 2018·9 cites·15 claims
- 1781US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 1881US10556968B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Feb 11, 2020·2 cites·8 claims
- 1981US9856317B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2016·Granted Jan 2, 2018·2 cites·19 claims
- 2080US7829090B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2004·Granted Nov 9, 2010·9 cites·22 claims
- 2179US2023340152A1Binding molecules specific for cd73 and uses thereofMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 2277US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 2377US9085628B2Antibody molecule for human GM-CSF receptor alphaMEDIMMUNE LTD·Filed 2013·Granted Jul 21, 2015·2 cites·16 claims
- 2474US7928214B2P-cadherin antibodiesAGOURON PHARMA·Filed 2008·Granted Apr 19, 2011·2 cites·12 claims
- 2574US2021147559A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2673US8187603B2Antibodies to human IL-22GILL DAVINDER S·Filed 2009·Granted May 29, 2012·1 cites·24 claims
- 2772US11525012B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Dec 13, 2022·0 cites·6 claims
- 2872US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 2971US9315575B2Methods of treatment using human antibody molecules for IL-13MONK PHILLIP DAVID·Filed 2010·Granted Apr 19, 2016·2 cites·72 claims
- 3071US8470993B2Nucleic acid encoding antibody to human IL-22GILL DAVINDER S·Filed 2012·Granted Jun 25, 2013·1 cites·19 claims
- 3169US8182817B2Antibodies to human IL-22GILL DAVINDER S·Filed 2010·Granted May 22, 2012·1 cites·20 claims
- 3269US2021130442A1Anti-pseudomonas psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 3367US2019309077A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 3466US8518645B2Method of mutagenesisMINTER RALPH RAYMOND·Filed 2006·Granted Aug 27, 2013·1 cites·41 claims
- 3566US2022195037A1Compositions and methods for inhibiting cancer stem cellsMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 3665US2019040145A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 3762US8974781B2P-cadherin antibodiesBAUER CHRISTOPHER TODD·Filed 2011·Granted Mar 10, 2015·1 cites·9 claims
- 3862US2018230209A1Human antibody molecules for il-13MEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 3958US10329345B2Stabilized angiopoietin-2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Jun 25, 2019·0 cites·15 claims
- 4058US2025304666A1Anti-complement factor h antibodiesALCHEMAB THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 4157US2015376285A1Antibody Molecule For Human GM-CSF Receptor AlphaMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 4256US11192948B2Compositions and methods for inhibiting cancer stem cellsMEDIMMUNE LTD·Filed 2016·Granted Dec 7, 2021·0 cites·13 claims
- 4356US2024228604A1Anti-unc5c antibodiesALCHEMAB THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 4455US2025197819A1Fusion proteins comprising an e2 ubiquitin or ubiquitin-like conjugating domain and a targeting domain for specific protein degradationMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 4553US2013280251A1Stabilized Angiopoietin-2 Antibodies And Uses ThereofBEDIAN VAHE·Filed 2013·Application pending·0 cites
- 4648US2023192821A1Polypeptides encoding antibodies binding to sars-cov-2 spike proteinALCHEMAB THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4748US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 4845US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 4944US2018208639A1CTLA-4 VariantsMEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 5037US2017226158A1Intracellular antigen bindingMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →